Back to expert views

Risk and incidence of recurrent CV events post-ACS: a meta-analysis - Prof. Michael Gibson

Listen to Prof. Michael Gibson discuss the risks associated with early and late recurrent events in patients with recent ACS, and the implications this could have on trial design.

Prof. C. Michael Gibson

ACC21

Agenda

Continue to

Susan Gabriel, Ph.D.
ESC22

Recurrent CV events post-AMI in patients with MVD: A retrospective study in the UK

Listen to Dr. Susan Gabriel share her insights on risk factors for recurrent cardiovascular events following myocardial infarction in a large real-world data analysis of 78,000 patients with multivessel disease.

Listen Now
Dr. C. Michael Gibson, Dr. Serge Korijan
AHA22

Residual Cardiovascular Risk Despite Secondary Prevention: Data from Contemporary Cardiovascular Outcomes Trials From 2010-2021

Listen to Dr. C. Michael Gibson and Dr. Serge Korjian discuss expert insights on the recurrent cardiovascular risk in patients with contemporary CV outcomes trials between 2010-2021.  

Listen Now

Abbreviations

ACC, American College of Cardiology; ACS, acute coronary syndrome; AHA, American Heart Association; AMI, acute myocardial infarction; ApoA-I, apolipoprotein A-I; ASCVD, atherosclerotic cardiovascular disease; CV, cardiovascular; ESC, European Society of Cardiology; HDL, high-density lipoprotein; LDL, low-density lipoprotein 

 

USA-GEN-0051 | August 2023